Core Laboratories N.V.
CLB | NYSE
$8.93
-$0.72 (-7.46%)
At close: Nov 5, 2026, 4:00 PM ET
$8.93
$0.00 (0.00%)
After-hours:
Nov 5, 2026, 4:01 PM ET
Fiscal Year Period Ending | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 | FY 2020 Dec 31, 2020 |
|---|---|---|---|---|---|---|
PE Ratio | 23.57 | 25.84 | 22.35 | 48.26 | 51.88 | -12.16 |
PEG Ratio | 15.79 | -1.70 | 0.25 | -20.75 | -0.43 | 0.06 |
PS Ratio | 1.42 | 1.55 | 1.62 | 1.92 | 2.18 | 2.42 |
PB Ratio | 2.80 | 3.22 | 3.67 | 5.10 | 6.56 | 16.49 |
P/FCF Ratio | 33.44 | 18.72 | 58.02 | 63.72 | 44.55 | 25.64 |
P/OCF Ratio | 20.13 | 14.40 | 33.26 | 37.63 | 28.06 | 20.38 |
OCF/S Ratio | 7.03 | 10.76 | 4.86 | 5.10 | 7.78 | 11.88 |
Debt / Equity Ratio | 0.62 | 0.71 | 0.96 | 1.21 | 1.60 | 4.57 |
Quick Ratio | 1.51 | 1.71 | 1.72 | 1.47 | 1.58 | 1.42 |
Current Ratio | 2.02 | 2.32 | 2.53 | 2.05 | 2.08 | 1.85 |
Asset Turnover | 0.90 | 0.89 | 0.87 | 0.85 | 0.81 | 0.86 |
Interest Coverage | 4.78 | 4.73 | 4.07 | 3.59 | 4.95 | -5.34 |
Return on Equity | 11.15% | 12.46% | 16.31% | 10.56% | 12.61% | -136.53% |
Return on Assets | 5.08% | 5.32% | 6.25% | 3.36% | 3.40% | -17.17% |
Return on Invested Capital | 6.83% | 8.10% | 9.65% | 5.60% | 5.04% | -15.67% |
Dividend Yield | 0.25% | 0.23% | 0.23% | 0.20% | 0.18% | 1.06% |
Payout Ratio | 6.30% | 5.97% | 5.09% | 9.53% | 9.30% | -12.75% |
FCF Payout Ratio | 12.33% | 4.74% | 781.59% | 26.53% | 46.47% | 32.25% |
Gross Profit Margin | 17.91% | 16.87% | 18.45% | 16.11% | 17.83% | 20.96% |
Net Profit Margin | 5.63% | 5.99% | 7.19% | 3.97% | 4.20% | -20.04% |
Pretax Profit Margin | 8.72% | 8.82% | 8.08% | 6.12% | 7.68% | -18.71% |
Operating Profit Margin | 9.59% | 11.18% | 10.72% | 8.48% | 9.63% | -15.76% |
FCF Margin | 4.23% | 8.28% | 2.79% | 3.01% | 4.90% | 9.44% |
EBITDA Margin | 13.51% | 14.03% | 13.81% | 11.98% | 13.56% | 14.47% |
Add to Watchlist
Select watchlists to add or remove CLB